Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP science news

Show

From To
High levels of unmet need for family planning in people with HIV - couples unaware of conception and contraception options

In Kenya, Tanzania and Namibia, just 46% of HIV-positive women and 28% of HIV-positive men have discussed family planning with a healthcare provider, delegates were told at the

Published
26 July 2011
By
Roger Pebody
Gay men’s PrEP study final results: near 90% efficacy in men who took drug, but adherence even lower than thought

A completed series of investigations into the iPrEx study of tenofovir/FTC(Truvada) as pre-exposure prophylaxis (PrEP) has found that the drug was 92% efficacious in preventing HIV infection

Published
22 July 2011
By
Gus Cairns
From 'what if' to 'what now': implementing the new prevention technologies

Two consecutive sessions at the sixth International AIDS Society conference (IAS 2011) in Rome yesterday were devoted, now we have convincing scientific data on the benefits of

Published
20 July 2011
By
Gus Cairns
Small study shows women on stable HIV therapy have very low levels of HIV and high drug concentrations in genital fluids

A study of paired samples collected from the blood and cervico-vaginal fluid (CVF) of 20 women on stable antiretroviral therapy has found little evidence that there are

Published
19 July 2011
By
Gus Cairns
Pre-exposure prophylaxis does work for women, two studies find

Two studies of the use of oral pre-exposure prophylaxis (PrEP) in heterosexual people show that oral PrEP will protect women against HIV. The 6th International AIDS Society

Published
19 July 2011
By
Gus Cairns
The research agenda for antiretroviral prevention – now it gets complex

We now know that starting antiretroviral therapy early, pre-exposure prophylaxis (PrEP) and vaginal microbicides can all have an impact on HIV transmission, Victor de Gruttola told a satellite

Published
18 July 2011
By
Roger Pebody
Rome IAS conference is 'landmark moment' for HIV science, say experts

The Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opened on Sunday night in Rome amid great excitement, with scientific

Published
17 July 2011
By
Keith Alcorn
Antiretroviral prevention methods 'not in competition' with each other

Antiretroviral prevention methods are not in competition, and policy makers and providers need to start to thinking about how antiretrovirals, pre-exposure prophylaxis and microbicides will be provided

Published
17 July 2011
By
Keith Alcorn
Two major studies show that HIV drugs prevent infection

Two large studies of pre-exposure prophylaxis – use of antiretroviral drugs by uninfected people to prevent HIV infection – have shown that taking tenofovir or tenofovir plus

Published
13 July 2011
By
Keith Alcorn
Study of HIV drug for prevention in women closes, judged unlikely to show effect

A large study of pre-exposure prophylaxis (PrEP) in women is to close after investigators concluded that even if it carries on to its originally planned conclusion, the

Published
18 April 2011
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.